EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSLBEG00000021190
Gene Symbol: IDH1
3 Cross references
233 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp] Cytoplasmic-Like

Ensembl ID : ENSLBEG00000019003
Gene Symbol: LOC109978577
3 Cross references
233 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSLBEG00000006568
Gene Symbol: LOC109999297
3 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial-Like

Ensembl ID : ENSLBEG00000007152
Gene Symbol: LOC109999774
3 Cross references
186 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSLBEG00000020837
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSLBEG00000020516
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSLBEG00000001240
Gene Symbol: KIF11
3 Cross references
201 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSLBEG00000026709
Gene Symbol: KIF5B
4 Cross references
234 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSLBEG00000000712
Gene Symbol: KIF5B
4 Cross references
236 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSLBEG00000026632
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSLBEG00000004664
Gene Symbol: LOC109997472
3 Cross references
166 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSLBEG00000015827
Gene Symbol: LOC109999492
3 Cross references
157 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).